{"id":"W2944582362","doi":"10.1056/nejmoa1901981","title":"Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":true,"ca_institutions":"NeuroRx Research (Canada); University of Toronto; St. Michael's Hospital","funders":"Merck KGaA","keywords":"Placebo; Multiple sclerosis; Medicine; Bruton's tyrosine kinase; Internal medicine; Clinical trial; Oncology; Pharmacology; Alternative medicine; Immunology; Pathology; Tyrosine kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003242413,0.0001863807,0.001461273,0.0005411264,0.0000175638,0.000007000184,0.0002115562,0.0001387633,0.0005638839],"category_scores_gemma":[0.002472783,0.000114274,0.0001576846,0.0003214288,0.0001321021,0.000157398,0.00003535396,0.0005638629,0.0000129201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001424534,"about_ca_system_score_gemma":0.004559037,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007056457,"about_ca_topic_score_gemma":0.0001673003,"domain_scores_codex":[0.9967551,0.0002710378,0.001225422,0.0001876812,0.001226557,0.0003341688],"domain_scores_gemma":[0.9974899,0.000946257,0.0004731387,0.0003345602,0.000288345,0.0004677755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9300771,0.0005770772,0.002931915,0.0001248015,0.0001914953,0.0004200682,0.001182184,0.0001241678,0.02483534,0.00001966083,0.001591799,0.03792435],"study_design_scores_gemma":[0.9771411,0.01230235,0.0009627941,0.001043083,0.0001588499,0.000684223,0.0002515001,0.003425531,0.002328587,0.00006423552,0.001545007,0.00009272791],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947636,0.0004472264,0.00002544621,0.001389456,0.001039575,0.001298866,0.000001228662,0.000008156319,0.001026415],"genre_scores_gemma":[0.9944869,0.0001757392,0.0004593061,0.0001377082,0.003970768,0.000005524516,0.000004695641,0.00002613264,0.0007332739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04706397,"threshold_uncertainty_score":0.8087536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04527378136246739,"score_gpt":0.3088913223947608,"score_spread":0.2636175410322934,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}